Yi, M., Tong, G
A 62-year-old female patient with a history of type 1 diabetes mellitus, obesity, and hypertension developed fixed drug eruption following semaglutide administration, representing the first reported case of this reaction to the glucagon-like peptide-1 receptor agonist, according to researchers at Temple University Lewis Katz School of Medicine
If you want to keep your body weight in check, you will need to make sure that you keep your fat cells happy and inflammation-free
Edelman: SGLT2 inhibitors (Farxiga, Invokana, Jardiance, Steglatro) and GLP1-RAs (Adlyxin, Byetta/Bydureon, Ozempic, Rybelsus, Trulicity, Victoza) have now become two of the most important classes of medications for type 2 diabetes
Despite appearing promising, it remains unclear whether the positive effects of triple agonists differ from those seen in dual GLP-1/GIP agonists